Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic.

Papa AL, Sidiqui A, Balasubramanian SU, Sarangi S, Luchette M, Sengupta S, Harfouche R.

Cell Oncol (Dordr). 2013 Dec;36(6):449-57. doi: 10.1007/s13402-013-0146-4. Epub 2013 Oct 1.

PMID:
24081907
[PubMed - in process]
2.

The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept.

Mirjolet C, Papa AL, Créhange G, Raguin O, Seignez C, Paul C, Truc G, Maingon P, Millot N.

Radiother Oncol. 2013 Jul;108(1):136-42. doi: 10.1016/j.radonc.2013.04.004. Epub 2013 May 4.

PMID:
23647757
[PubMed - indexed for MEDLINE]
3.

P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.

Sarangi S, Pandey A, Papa AL, Sengupta P, Kopparam J, Dadwal U, Basu S, Sengupta S.

Med Oncol. 2013;30(2):567. doi: 10.1007/s12032-013-0567-y. Epub 2013 Apr 9.

PMID:
23568163
[PubMed - indexed for MEDLINE]
4.

Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.

Papa AL, Basu S, Sengupta P, Banerjee D, Sengupta S, Harfouche R.

BMC Cancer. 2012 Sep 22;12:419. doi: 10.1186/1471-2407-12-419.

PMID:
22998550
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Titanate nanotubes: towards a novel and safer nanovector for cardiomyocytes.

Papa AL, Dumont L, Vandroux D, Millot N.

Nanotoxicology. 2013 Sep;7(6):1131-42. doi: 10.3109/17435390.2012.710661. Epub 2012 Aug 13.

PMID:
22770363
[PubMed - indexed for MEDLINE]
6.

Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.

Paraskar A, Soni S, Roy B, Papa AL, Sengupta S.

Nanotechnology. 2012 Feb 24;23(7):075103. doi: 10.1088/0957-4484/23/7/075103.

PMID:
22275055
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk